ArisGlobal Earns Frost & Sullivan's 2025 New Product Innovation Recognition for Agentic AI in Pharmacovigilance
ArisGlobal has been recognized by Frost & Sullivan with the 2025 Global New Product Innovation Recognition in Intelligent MedDRA Coding. The nod centers on ArisGlobal's MedDRA Coding Agent-an agentic AI launched in April 2025 that codes safety data with human-like judgment, transparency, and speed.
Built on LifeSphere NavaX, the agent moves past static rules and brittle automations. It interprets clinical language in context, reasons through edge cases, and learns from reviewer feedback in real time.
What makes the MedDRA Coding Agent different
- Agentic understanding of context: Interprets meaning and intent, not just keywords.
- Continuous learning loop: Adapts to reviewer input and evolving MedDRA terminology.
- Explainable and auditable: Surfaces rationale behind each decision to support compliance.
- Multilingual and enterprise-ready: Built for global teams, integrations, and validation requirements.
- Adaptive collaboration: Escalates only when needed, offering ranked, rationale-based coding options.
Teams report significant reductions in manual review and more consistent coding outcomes across large, distributed operations. The result: faster throughput without sacrificing accuracy or auditability.
Why product leaders should care
- Clear ROI path: Frost & Sullivan cites potential efficiency gains of up to 80%, easing reviewer workload while maintaining accuracy.
- Human-in-the-loop by design: Reviewers train the system as they work, improving results week over week.
- Lower operational noise: Fewer escalations, fewer reworks, and cleaner decision trails for inspections.
- Scales globally: Multilingual support and enterprise integrations help standardize coding across regions and partners.
Independent validation from Frost & Sullivan
Frost & Sullivan commended ArisGlobal for reimagining pharmacovigilance with context-aware, agentic systems that deliver measurable operational and compliance benefits. "The MedDRA Coding Agent is adaptive, auditable, and enterprise-ready, enabling up to 80% efficiency gains... while maintaining uncompromising accuracy," said Norazah Bachok, Best Practices Research Analyst at Frost & Sullivan.
The recognition comes from Frost & Sullivan's Best Practices program, which highlights leadership, innovation, and customer impact across industries. ArisGlobal stood out for strategy execution, alignment with market needs, and operational excellence.
How it fits into your stack
This agent is built for regulated environments. It integrates with enterprise systems, explains each decision for audit readiness, and respects validation needs across regions.
- Pilot focus: Start with high-volume case types where reviewers spend the most time.
- Integration: Connect to your safety database and coding workflows; align cross-functional owners early (PV, QA, IT).
- Feedback loop: Treat reviewer corrections as training fuel; set weekly targets for accuracy and auto-accept rates.
- Compliance: Lock down audit trails, decision rationales, and versioning for inspections.
What ArisGlobal says
"The MedDRA Coding Agent represents a major leap forward in pharmacovigilance automation," said Jason Bryant, SVP, Product Management - AI at ArisGlobal. "By combining the cognitive depth of agentic AI with the proven capabilities of LifeSphere NavaX, we're transforming complex coding workflows into smart, adaptive processes that deliver greater accuracy and efficiency at scale."
What's next
ArisGlobal notes this is the first in a series of agent-based capabilities planned across Safety and Regulatory. Expect expansion into adjacent workflows where context, auditability, and throughput matter most.
Resources
Your membership also unlocks:
